Safety and efficacy of targeted intraoperative radiotherapy (TARGIT) for early breast cancer: First report of a randomized controlled trial at 10-years maximum follow-up. - Baum,M.; Joseph,D.J.; Tobias,J.S. (J Clin Oncol, 2010)